article thumbnail

STAT+: Eli Lilly’s stock falls after 2024 guidance misses forecasts

STAT

The company also expects revenue from all of 2024 to be $45 billion, lower than the range of $45.4 Lilly said the GLP-1 drugs Mounjaro and Zepbound are expected to have brought in $3.5 billion and $1.9 billion, respectively, in the fourth quarter. billion to $46 billion that it had previously guided.

Diabetes 275
article thumbnail

Opinion: Will PBM reform save pharmacies from closing?

STAT

In May 2024 , nearly 90% of pharmacies were closed for a day as thousands of pharmacists protested over “over drug shortages, pharmacy closures and fears medications could be sold online, as well as higher pay.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

2024 Nobel prize in medicine: Ruvkun, Ambros win for discovery of microRNA

STAT

LONDON — A pair of scientists who discovered a type of RNA molecule that helps control the activity of genes — allowing our cells to perform all their myriad of functions in different tissues throughout the body — won the 2024 Nobel Prize in medicine or physiology on Monday.

363
363
article thumbnail

STAT+: 3 trends to watch in biotech in 2024

STAT

But after two years of steady decline, 2024 might finally prove them right. Here are three major themes that we expect to drive the news in 2024 and determine whether biotech’s comeback is a sustainable trend or an interest-rate phenomenon.

336
336
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations.

article thumbnail

November-December 2024

Safe Biologics

ASBM Exhibits at ACR Convergence 2024 During November, ASBM was proud to again participate in the American College of Rheumatology (ACR) Convergence 2024, held from November 14-19 in Washington, DC. Read more about ACR Convergence 2024 here. The approval of Steqeyma brings the total number of biosimilars approved in 2024 to 17.

article thumbnail

STAT+: 3 CRISPR advances to watch in 2024

STAT

Here are three CRISPR developments we’re watching in 2024: Continue to STAT+ to read the full story… The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

338
338
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

📅 October 15, 2024 at 11:00 am PT, 2:00 pm ET, 7:00 pm GMT Don’t miss this exclusive session - register today to save your seat!

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

📆 November 21, 2024 at 11:00 AM PST, 2:00 PM EST, 7:00 PM GMT